--2025/Q1-- / 14.888M--
--2024/Q4-- / 12.877M--
--2024/Q312.588M / 12.253M--
--2024/Q212.092M / 21.784M--
--2024/Q116.585M / 17.085M--
Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
NRIX Nurix Therapeutics
- 20.270
- -0.290-1.41%
Close Dec 13 16:00 ET
- 20.270
- 0.0000.00%
Post 16:20 ET
1.44BMarket Cap-6.99P/E (TTM)
20.845High19.900Low739.21KVolume20.400Open20.560Pre Close14.95MTurnover1.28%Turnover RatioLossP/E (Static)70.84MShares29.56052wk High3.81P/B1.17BFloat Cap7.65052wk Low--Dividend TTM57.74MShs Float52.380Historical High--Div YieldTTM4.60%Amplitude4.220Historical Low20.224Avg Price1Lot Size
Nurix Therapeutics Key Stats
Nurix Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Nurix Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data